Open AccessUse of tenofovir disoproxil fumarate is associated with a lower risk of hepatocellular carcinoma than entecavir in patients with chronic hepatitis B
Author(s) -
WonMook Choi,
Jonggi Choi
Publication year - 2021
Publication title -
hepatoma research
Language(s) - English
Resource type - Journals
eISSN - 2454-2520
pISSN - 2394-5079
DOI - 10.20517/2394-5079.2021.113
Subject(s) - entecavir , medicine , hepatocellular carcinoma , tenofovir , chronic hepatitis , hepatitis b , gastroenterology , virology , oncology , virus , lamivudine , human immunodeficiency virus (hiv)